298 related articles for article (PubMed ID: 23143508)
21. Proteomic Insights into Osteoporosis: Unraveling Diagnostic Markers of and Therapeutic Targets for the Metabolic Bone Disease.
Wang J; Xue M; Hu Y; Li J; Li Z; Wang Y
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785961
[TBL] [Abstract][Full Text] [Related]
22. [Guideline for adequate use of metabolic bone markers in osteoporosis].
Nishizawa Y; Nakatsuka K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():325-32. PubMed ID: 15035146
[No Abstract] [Full Text] [Related]
23. First update of the Lebanese guidelines for osteoporosis assessment and treatment.
Fuleihan Gel-H; Baddoura R; Awada H; Okais AA
J Med Liban; 2007; 55(4):176-91. PubMed ID: 18782973
[TBL] [Abstract][Full Text] [Related]
24. Biochemical markers of bone turnover. Applications for osteoporosis.
Garnero P; Delmas PD
Endocrinol Metab Clin North Am; 1998 Jun; 27(2):303-23. PubMed ID: 9669140
[TBL] [Abstract][Full Text] [Related]
25. [Bone metabolic markers in osteoporosis].
Shiraki M; Chen JT; Aoki C; Hosoda K
Nihon Rinsho; 1994 Sep; 52(9):2305-11. PubMed ID: 7967073
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic imaging and biochemical markers of bone turnover.
Kessenich CR
Nurs Clin North Am; 2001 Sep; 36(3):409-16, viii. PubMed ID: 11532656
[TBL] [Abstract][Full Text] [Related]
27. Bone turnover marker monitoring in osteoporosis treatment response.
Tan RZ; Loh TP; Vasikaran S
Eur J Endocrinol; 2020 Jun; 183(1):C5-C7. PubMed ID: 32504486
[No Abstract] [Full Text] [Related]
28. ['Osteoporosis' guideline from the Dutch Society for General Practitioners].
Dofferhoff AS; Go IH
Ned Tijdschr Geneeskd; 1999 Oct; 143(40):2027-8. PubMed ID: 10535061
[No Abstract] [Full Text] [Related]
29. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.
Cremers S; Garnero P
Drugs; 2006; 66(16):2031-58. PubMed ID: 17112299
[TBL] [Abstract][Full Text] [Related]
30. [Current diagnosis and therapy of osteoporosis on the basis of "European guidance 2008"].
Bartl R; Gradinger R
Orthopade; 2009 Apr; 38(4):365-79; quiz 380. PubMed ID: 19305966
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers of Osteoporosis: An Update.
Parveen B; Parveen A; Vohora D
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):895-912. PubMed ID: 30727928
[TBL] [Abstract][Full Text] [Related]
32. Osteoporosis update from the 2012 Santa Fe Bone Symposium.
Lewiecki EM; Adler RA; Bilezikian JP; Bouxsein ML; Marcus R; McClung MR; Miller PD; Tanner SB; Randall S
J Clin Densitom; 2013; 16(4):584-600. PubMed ID: 23419827
[TBL] [Abstract][Full Text] [Related]
33. Clinical Application of Bone Turnover Markers in Osteoporosis in Korea.
Park SY; Ahn SH; Yoo JI; Chung YJ; Jeon YK; Yoon BH; Kim HY; Lee SH; Lee J; Hong S
J Bone Metab; 2019 Feb; 26(1):19-24. PubMed ID: 30899720
[TBL] [Abstract][Full Text] [Related]
34. Bone markers.
Garnero P; Delmas PD
Baillieres Clin Rheumatol; 1997 Aug; 11(3):517-37. PubMed ID: 9367035
[TBL] [Abstract][Full Text] [Related]
35. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring.
Garnero P
Mol Diagn Ther; 2008; 12(3):157-70. PubMed ID: 18510379
[TBL] [Abstract][Full Text] [Related]
37. Osteoporosis in childhood: bone density of children in health and disease.
van der Sluis IM; de Muinck Keizer-Schrama SM
J Pediatr Endocrinol Metab; 2001; 14(7):817-32. PubMed ID: 11515724
[TBL] [Abstract][Full Text] [Related]
38. Biochemical markers in osteoporosis: usefulness in clinical practice.
Romero Barco CM; Manrique Arija S; Rodríguez Pérez M
Reumatol Clin; 2012; 8(3):149-52. PubMed ID: 22089065
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and management of patients with diabetes and co-existing osteoporosis (Update 2019) : Common guideline of the Autrian Society for Bone and Mineral Research and the Austrian Diabetes Society].
Muschitz C; Kautzky-Willer A; Rauner M; Winhöfer-Stöckl Y; Haschka J
Wien Klin Wochenschr; 2019 May; 131(Suppl 1):174-185. PubMed ID: 30980167
[TBL] [Abstract][Full Text] [Related]
40. [Prescription of bone remodeling markers in hospitals].
Souberbielle JC; Carlier MC; Bianchi F; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Garnero P
Ann Biol Clin (Paris); 2002; 60(5):571-9. PubMed ID: 12368143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
